[{"address1": "3963 Maple Avenue", "address2": "Suite 350", "city": "Dallas", "state": "TX", "zip": "75219", "country": "United States", "phone": "972 499 3350", "website": "https://instilbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bronson  Crouch", "age": 51, "title": "Chairman & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1140189, "exercisedValue": 0, "unexercisedValue": 35349}, {"maxAge": 1, "name": "Dr. Sandeep  Laumas M.D.", "age": 55, "title": "CFO & Chief Business Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 741521, "exercisedValue": 0, "unexercisedValue": 61910}, {"maxAge": 1, "name": "Dr. Mark E. Dudley Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 23.85, "open": 23.8, "dayLow": 21.5082, "dayHigh": 23.8, "regularMarketPreviousClose": 23.85, "regularMarketOpen": 23.8, "regularMarketDayLow": 21.5082, "regularMarketDayHigh": 23.8, "beta": 1.724, "forwardPE": -1.4759461, "volume": 98271, "regularMarketVolume": 98271, "averageVolume": 97957, "averageVolume10days": 68140, "averageDailyVolume10Day": 68140, "bid": 16.59, "ask": 23.25, "bidSize": 200, "askSize": 100, "marketCap": 150160736, "fiftyTwoWeekLow": 9.62, "fiftyTwoWeekHigh": 92.0, "fiftyDayAverage": 22.2967, "twoHundredDayAverage": 22.782675, "currency": "USD", "enterpriseValue": 114362656, "floatShares": 2364459, "sharesOutstanding": 6525890, "sharesShort": 696978, "sharesShortPriorMonth": 587920, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.106800005, "heldPercentInsiders": 0.1282, "heldPercentInstitutions": 0.84266, "shortRatio": 6.53, "shortPercentOfFloat": 0.1848, "impliedSharesOutstanding": 6525890, "bookValue": 27.023, "priceToBook": 0.8514969, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -75165000, "trailingEps": -11.56, "forwardEps": -12.07, "lastSplitFactor": "1:20", "lastSplitDate": 1701993600, "enterpriseToEbitda": -2.01, "52WeekChange": 1.0160608, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TIL", "underlyingSymbol": "TIL", "shortName": "Instil Bio, Inc.", "longName": "Instil Bio, Inc.", "firstTradeDateEpochUtc": 1616160600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f6e98ce3-ca96-34e6-a1c6-796bed2d60df", "messageBoardId": "finmb_638929728", "gmtOffSetMilliseconds": -18000000, "currentPrice": 23.01, "targetHighPrice": 180.0, "targetLowPrice": 52.0, "targetMeanPrice": 114.0, "targetMedianPrice": 110.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 121143000, "totalCashPerShare": 18.563, "ebitda": -56910000, "totalDebt": 85345000, "quickRatio": 11.784, "currentRatio": 12.896, "debtToEquity": 48.4, "returnOnAssets": -0.12404, "returnOnEquity": -0.36633998, "freeCashflow": -24233376, "operatingCashflow": -58518000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]